Last reviewed · How we verify

NCT05247762

Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma

Completed NA Last updated 10 April 2024
What this trial tests

NA trial testing Acupuncture in Primary Open-angle Glaucoma in 40 participants. Completed in 30 November 2023.

Timeline
28 February 2022
Primary endpoint
30 November 2023
30 November 2023

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date28 February 2022
Primary completion30 November 2023
Estimated completion30 November 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

Adults 20 to 75, any sex, with Primary Open-angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test the therapeutic effect of acupuncture at the Jingming and the Qiuhou acupoints on the visual acuity and visual field in patients with primary open-angle glaucoma. Participants will get acupuncture or Wangbuliu Xingzi Paste (sham acupuncture) on both sides of the Jingming and the Qiuhou, once a week, once for 20 minutes, for 24 weeks. Researchers will compare acupuncture group and sham acupuncture group to see if the visual acuity, visual field, intraocular pressure, optic nerve fiber layer thickness, serum homocysteine concentration, and scores on the WHOQOL-REF (Taiwan version) scale would be improved.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

Other recruiting trials for Primary Open-angle Glaucoma

Currently open trials in the same condition.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05247762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing